RLYB   $0.5602  -5.00% Market Closed

Rallybio Corporation
Total Cash 88.61M
totalCashPerShare 2.136
EBITDA -73.86M
Total Debt 284.00K
quickRatio 7.287
currentRatio 7.519
Total Revenue 299.00K
debtToEquity 0.355
Revenue/Share 0.007
ROA -0.38539
ROE -0.67387
grossProfits
freeCashflow -26.66M
operatingCashflow -53.99M
earningsGrowth
revenueGrowth
grossMargins 2.50502
ebitdaMargins 0.0
operatingMargins -56.973244
profitMargins 0.0
enterpriseValue -46.84M
forwardPE -0.729927
floatShares 18.98M
sharesOutstanding 41.49M
sharesShort 536.63K
sharesShortPriorMonth 579.07K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.77%
Short Ratio help_outline 10.09%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 1.929
Price To Book help_outline 0.52
earningsQuarterlyGrowth
netIncomeToCommon -73.88M
trailingEps -1.73%
forwardEps -1.37%
enterpriseToEbitda 0.63
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.35 3Q 2024
institutionsCount 74
lastUpdated Nov. 7, 2024, 5:13 a.m.